New ‘Super Test’ for Prostate Cancer Developed in the UK by EDX Medical

Contributed by: Business Wire

Logo

Tags

Technology

Medical Devices

Genetics

Health Technology

Biotechnology

Pharmaceutical

Health

Data Management

Oncology

Artificial Intelligence

EDX Medical Group plc

More Like This

NEW TESTS TO IDENTIFY HEREDITARY CANCER RISKS TO BE LAUNCHED

EDX Medical to Market Pioneering Cancer Drugs Response Assay in UK and Nordics

PR Newswire associated0

SCIENTISTS PIONEER DEVELOPMENT OF MULTI-DISEASE RAPID TESTS AS EDX MEDICAL PLC COMPLETES ACQUISITION OF HUTANO DIAGNOSTICS LTD

EDX Medical Announces Agreement With Caris Life Sciences to Distribute Molecular Profiling in the United Kingdom and Nordic Countries

PR Newswire associated0

EDX MEDICAL ANNOUNCES COLLABORATION WITH THERMO FISHER SCIENTIFIC TO DEVELOP INNOVATIVE CANCER TESTS FOR GLOBAL HEALTHCARE MARKETS

PR Newswire associated0

TESTCARD TEST KIT: GROUNDBREAKING NEW TRIAL FOR PROSTATE CANCER SCREENING IN THE HOME

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®